Patrick J. Scannon,Alan M. Solinger,Robert J. Bauer
申请号：
US13062457
公开号：
US08545846B2
申请日:
2009.09.04
申请国别(地区):
US
年份:
2013
代理人:
摘要：
Disclosed are methods for the treatment and/or prevention of Type 2 diabetes, insulin resistance and disease states and conditions characterized by insulin resistance, decreased insulin production, hyperglycemia, hypoinsulinemia, metabolic syndrome, Type 1 diabetes and obesity, comprising administering to a subject an effective amount of anti-IL-1β antibody or fragment thereof.
